caloric consumption

Deutsche Bank has recently conducted a survey suggesting that patients using Novo Nordisk A/S (NYSE:NVO) weight loss medication, Ozempic, may increase their caloric intake after discontinuing the treatment. What Happened: The survey involved 600 U.S. consumers. Seventy percent of the participants ...